28mon MSN
50+ branded semaglutide generics to enter India as diabetes drug patent expires in March 2026
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results